selected publications
-
academic article
- A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.. Gastroenterology. 160:115-127.e30. 2021
- SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 72:2132-2140. 2021
- Two hour bivalirudin infusion after PCI for ST elevation myocardial infarction.. Journal of thrombosis and thrombolysis. 31:401-406. 2011